Stockscreener 앱 받기
16.52
1.37%
-0.23
시장 영업 전:
16.52
Adma Biologics Inc 주식(ADMA)의 최신 뉴스
ADMA projects $1.1B revenue before 2030 as yield enhancement drives margin expansion and ASCENIV growth - MSN
How did ADMA's revenue surge in Q4 2024 impact its profitability? - AInvest
ADMA Biologics: Optionality With SG-001 And A Vertically Integrated IG Platform - Seeking Alpha
ADMA Beats on Q2 Earnings and Revenues, Asceniv Drives Momentum - MSN
ADMA Biologics Thrives With Blockbuster Growth And New FDA Edge - Finimize
ADMA Biologics: A Better Quarter Than Headline Numbers (NASDAQ:ADMA) - Seeking Alpha
ADMA Biologics, Inc. (NASDAQ:ADMA) Q2 2025 Earnings Call Transcript - Insider Monkey
ADMA Biologics 2025 Q2 Earnings Strong Performance as Net Income Rises 6.7% - AInvest
ADMA Biologics Secures $300M Credit Agreement with JPMorgan - AInvest
ADMA Biologics Earnings Call Highlights Robust Growth - TipRanks
Noteworthy Thursday Option Activity: ADMA, SMMT, ICHR - Nasdaq
ADMA Biologics Sees Promising Gains Amid Strategic Shifts and Rising Market Trends - timothysykes.com
Plasma Derived Medicine Market to Reach USD 37.4 Billion by 2034, Growing at 8.05% CAGR - GlobeNewswire Inc.
ADMA Beats On Q2 Earnings And Revenues, Asceniv Drives Momentum - Barchart.com
Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Earnings call transcript: ADMA Biologics Q2 2025 misses earnings expectations By Investing.com - Investing.com South Africa
Adma Biologics (ADMA) Q2 Revenue Up 14% - AOL.com
ADMA Biologics Reports Strong Q2 2025 Results - TipRanks
ADMA Biologics Q2 2025 Earnings Call Transcript - MarketBeat
ADMA Biologics Outpaces Expectations With Upbeat Growth Plans - Finimize
ADMA Biologics Rides ASCENIV Demand To Higher Guidance - Finimize
ADMA Biologics (ADMA) Projects Significant Growth with Yield Pro - GuruFocus
ADMA Biologics: A Tale of Two Narratives—Strong Fundamentals vs. a Pessimistic Rating - AInvest
ADMA Biologics' Q2 2025: Unraveling Contradictions in Yield Enhancements, Reimbursement, and Demand Dynamics - AInvest
ADMA Biologics Q2 2025 Earnings Call Transcript Review - AInvest
ADMA Biologics' Q2 2025 Earnings and Strategic Outlook: Navigating Insider Sales and Risk Disclosures for Long-Term Value - AInvest
ADMA Biologics Inc earnings missed, revenue fell short of estimates By Investing.com - Investing.com Canada
ADMA Biologics Inc earnings missed, revenue fell short of estimates - Investing.com
Transcript : ADMA Biologics, Inc., Q2 2025 Earnings Call, Aug 06, 2025 - MarketScreener
Adma Biologics (ADMA) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Adma Biologics: Q2 Earnings Snapshot - San Antonio Express-News
Adma Biologics Q2 Earnings: Impressive Growth in Net Income and RevenueNews and Statistics - IndexBox
ADMA BIOLOGICS, INC. SEC 10-Q Report - TradingView
Why ADMA Biologics Shares Are Under Pressure - TipRanks
ADMA Biologics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Adma Biologics reports Q2 EPS 14c, consensus 14c - TipRanks
ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update - The Manila Times
ADMA Biologics Reports 14% YoY Revenue Growth and Significant Financial Milestones in 2Q 2025 - Quiver Quantitative
Is ADMA Biologics Inc. a growth stock or a value stockDouble-digit growth - Jammu Links News
How strong is ADMA Biologics Inc. company’s balance sheetMaximize gains with data-driven trading alerts - Jammu Links News
What are analysts’ price targets for ADMA Biologics Inc. in the next 12 monthsFind the best stocks for sustainable growth - Jammu Links News
Is ADMA Biologics Inc. a good long term investmentAccelerated financial growth - Jammu Links News
Is ADMA Biologics Inc. stock overvalued or undervaluedOutstanding yields - Jammu Links News
Is it the right time to buy ADMA Biologics Inc. stockBuild a diversified portfolio for steady growth - Jammu Links News
What institutional investors are buying ADMA Biologics Inc. stockMaximize gains with timely market signals - Jammu Links News
What analysts say about ADMA Biologics Inc. stockInvest in high-yield stocks with confidence - Jammu Links News
What catalysts could drive ADMA Biologics Inc. stock higher in 2025Find the best stocks for sustainable growth - Jammu Links News
ADMA Biologics Inc. warns investors of significant business risks in latest report. - AInvest
What drives ADMA Biologics Inc. stock priceUnlock your trading potential with expert tips - Jammu Links News
0.24%
3.39%
자본화:
|
볼륨(24시간):